Blueprint Medicines (BPMC) to Release Earnings on Thursday themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Blueprint Medicines (NASDAQ:BPMC – Free Report) had its price target lifted by Barclays from $58.00 to $70.00 in a research report report published on Tuesday, Benzinga reports. The firm currently has an equal weight rating on the biotechnology company’s stock. Several other equities research analysts have also commented on the company. Needham & Company LLC […]
Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eleven brokerages that are presently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Analysts at Leerink Partnrs issued their Q1 2024 EPS estimates for shares of Kymera Therapeutics in a research report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will post earnings of ($0.79) per share for the quarter. Leerink Partnrs currently has […]
Torray Investment Partners LLC Increases Stock Position in Blueprint Medicines Co (NASDAQ:BPMC) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.